Gerardo Antonio Umanzor, MD of Liga Contra el Cáncer on paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: a Phase III clinical study in metastatic breast cancer.
Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer #SABCS19
